7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Invivyd Inc
(NASDAQ:IVVD) 

IVVD stock logo

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases in the United States. The company is headquartered in Waltham, Massachusetts.

Founded: 2020
Sector: LIFE SCIENCES
Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Share this website to your friends
Invivyd Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0278.26556.51834.771,113.031,391.291,669.541,947.8
Invivyd Days Inventory Outstanding ttm (DIO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -151.48-129.84-108.2-86.56-64.92-43.28-21.640
Invivyd Op Cashflow Per Share ttm
202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.27-1.94-1.62-1.3-0.97-0.65-0.320
Invivyd Free Cashflow Per Share ttm
202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.27-1.95-1.62-1.3-0.97-0.65-0.320
Invivyd Cash Per Share ttm
202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.551.11.652.212.763.313.86
Invivyd (GAAP) P/E ratio ttm
202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -3.2-2.74-2.28-1.83-1.37-0.91-0.460
Invivyd P/B ratio ttm
202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.30.60.91.21.491.792.09
No extra charts and metrics for this ticker.